Blog

FINNY Unveils Intent Search to Help Advisors Pinpoint High-Intent Prospects Faster

Prospect Enrichment and AI Voicemails round out the latest feature release to further accelerate advisor organic growthNEW YORK--(BUSINESS WIRE)--#AI--FINNY AI Inc. (“FINNY”), the AI-powered prospecting and marketing platform built specifically for financial advisors, today announced the launch of Intent Search, a feature that allows advisors to identify and engage with…
Leer más...

InspereX Survey: Financial Advisors Bullish on 2H 2025

Advisors see equities as top-performing, most volatile asset class for 2025 Volatility is good for business; advisors say it’s the “best time” to show valueDELRAY BEACH, Fla.--(BUSINESS WIRE)--According to the InspereX 2025 Advisor Pulse Outlook Survey of 829 financial advisors released today, more than two thirds (67%) of advisors said…
Leer más...

Encore Enterprises Doubles-Down on Dallas: Acquires Class B Commercial Medical Office Building, Reopens Corporate HQ as Owner-Occupied Tenant

Despite tough lending climate, banks’ continued struggle with commercial office portfolios, Encore secures loan on $7 million property through Cadence Bank in new relationshipDALLAS--(BUSINESS WIRE)--Encore Enterprises, Inc. (Encore) today announced the acquisition of a two-story, Class B medical office building at $114 PSF with 61,356 rentable square feet, located at…
Leer más...

Uniphore Launches Business AI Cloud: A Sovereign, Composable & Secure AI Platform to Power the Agentic Enterprise

New platform unifies agents, models, knowledge, and data to finally deliver on the promise of AI as a transformative force for businessPALO ALTO, Calif. & LONDON--(BUSINESS WIRE)--#AIAgents--Uniphore, the Business AI company, today launched the Uniphore Business AI Cloud: a sovereign, composable, and secure platform that bridges the “AI divide” between…
Leer más...

Cloud Range to Showcase Cutting-Edge Cybersecurity Simulations at 2025 Gartner Security & Risk Management Summit

Industry Leader Highlights Innovations in Cyber Preparedness TrainingNASHVILLE, Tenn.--(BUSINESS WIRE)--Cloud Range, the leading enterprise cyber range platform for reducing detection and response times thereby reducing cyber risk, today announced it will showcase its latest innovations in cyber readiness and pre-emptive preparedness at the 2025 Gartner Security & Risk Management Summit,…
Leer más...

Co-operators Transforms Claims Operations with Guidewire ClaimCenter on Guidewire Cloud Platform

Subsidiary Sovereign Insurance also leveraging ClaimCenter for claims managementGUELPH, Ontario & SAN MATEO, Calif.--(BUSINESS WIRE)--$GWRE #GuidewireBillingCenter--Co-operators, a leading Canadian multi-line insurance and financial services organization, and Guidewire (NYSE: GWRE) announced that Co-operators successfully implemented Guidewire ClaimCenter on Guidewire Cloud Platform to power its claims management functions, adapt to changing market…
Leer más...

Anodyne Nanotech Drives Major Advancement in the Treatment of Sarcopenia with Novel Muscle-Preserving Therapy

BOSTON--(BUSINESS WIRE)--Anodyne Nanotech, a clinical-stage biotech company, today announced new preclinical data demonstrating that administration of ANN-102 - an APJ receptor agonist via its proprietary HeroPatch™ microneedle system - significantly improved muscle strength, with efficacy equivalent to daily injections. These results lay the foundation for a novel, non-invasive, muscle-preserving therapy…
Leer más...

Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND® in Rare Blood Disorders

PYRUKYND® (mitapivat) is a first-in-class pyruvate kinase (PK) activator, approved by the European Commission for adults with PK deficiency The agreement includes commercialization and distribution rights for potential future indications Furthered by this partnership with Agios, Avanzanite is setting a new paradigm in biotech commercial and distribution partnerships, and in…
Leer más...

Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder

Results demonstrated that nicotinamide riboside (NR) significantly elevated NAD+ levels and improved multiple clinical markers in people with Werner Syndrome Niagen Bioscience expands rare disease research portfolio, supporting further investigation of NAD+ augmentation with NR as a therapeutic strategy in rare progeroid diseasesLOS ANGELES--(BUSINESS WIRE)--$NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE)…
Leer más...